Trough level-based dose reduction during infliximab maintenance treatment in Crohn's disease.
Phase of Trial: Phase II
Latest Information Update: 28 Nov 2017
At a glance
- Drugs Infliximab (Primary)
- Indications Crohn's disease
- Focus Therapeutic Use
- Acronyms REDIX
- 18 Sep 2014 Status changed from planning to unconfirmed as per Netherlands Trial Registry.
- 03 Jun 2014 According to the Netherlands Trial Registry, planned number of patients changed from 180 to 54.
- 03 Jun 2014 According to the Netherlands Trial Registry, planned end date changed from 1 Jun 2016 to 1 Jun 2017.